These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4424279)

  • 1. [Prostatic cancer--treatment with extramustine phosphate(Estracyt). An easier application form].
    Erichsen HG; Nygaard E
    Tidsskr Nor Laegeforen; 1974 Oct; 94(28):1901-2. PubMed ID: 4424279
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prostatic carcinoma with orally administered Estracyt].
    Mayer EJ
    Ther Umsch; 1975 Feb; 32(2):114-9. PubMed ID: 1118820
    [No Abstract]   [Full Text] [Related]  

  • 3. "Estracyt".
    Jönsson G
    Br J Urol; 1971 Dec; 43(6):732. PubMed ID: 5159576
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
    Müntzing J; Shukla SK; Chu TM; Mittelman A; Murphy GP
    Invest Urol; 1974 Jul; 12(1):65-8. PubMed ID: 4835492
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T; Haukaas S
    Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of prostatic carcinoma with Stilbostat.
    Zimel H; Bocancea D
    Neoplasma; 1974; 21(1):101-8. PubMed ID: 4596007
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group.
    Aro J; Ruutu M; Juusela H; Hansson E; Permi J
    Ann Chir Gynaecol Suppl; 1993; 206():5-8. PubMed ID: 8291869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estracyt in hormone-resistant prostatic carcinoma.
    Szendröi Z; Könyves I; Szendi L; Eckhardt S; Hartay F
    Int Urol Nephrol; 1974; 6(2):101-10. PubMed ID: 4448622
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.
    Lindstedt E
    Scand J Urol Nephrol Suppl; 1980; 55():95-7. PubMed ID: 6938044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytostatic treatment of prostatic carcinoma. Evaluation study of estramustinphosphate].
    Anderes A; Arquint A; Camponovo F; Deppeler O; Doerig R; Heim H; Humbert-Droz P; Jung HP; Magaro L; Sasso M; Vischer C; Wanner J; Wegmann HJ; Ziegler E
    Schweiz Rundsch Med Prax; 1971 Sep; 60(38):1276-9. PubMed ID: 5094915
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of advanced prostatic carcinoma using polyestradiol phosphate (Estradurin)].
    Bülow H
    Med Welt; 1980 Aug; 31(34):1215-7. PubMed ID: 6776381
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of prostatic cancer with local injection of estrogenic hormones].
    Kato T; Ishibe T; Fukushige M; Kajio K; Ito Y
    Hinyokika Kiyo; 1965 Jul; 11(7):602-4. PubMed ID: 5890823
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.
    Hedlund PO; Gustafson H; Sjögren S
    Scand J Urol Nephrol Suppl; 1980; 55():103-5. PubMed ID: 6938012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced prostatic carcinoma with Estracyt. A preliminary report.
    Jönsson G; Högberg B
    Scand J Urol Nephrol; 1971; 5(2):103-7. PubMed ID: 5093102
    [No Abstract]   [Full Text] [Related]  

  • 17. Estracyt in advanced prostatic carcinoma. Case report.
    Nilsson T; Müntzing J
    Scand J Urol Nephrol; 1972; 6(1):11-6. PubMed ID: 5057614
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estrogen popular again in prostatic cancer?].
    Hedlund PO
    Lakartidningen; 1992 Oct; 89(42):3467-9. PubMed ID: 1435047
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium.
    Mikkola A; Ruutu M; Aro J; Rannikko S; Salo J
    Ann Chir Gynaecol; 1999; 88(1):18-21. PubMed ID: 10230677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.